Annual ROE
282.15%
+672.09%+172.36%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual return on equity is 282.15%, with the most recent change of +672.09% (+172.36%) on December 31, 2023.
- During the last 3 years, CLRB annual ROE has risen by +309.70% (+1124.14%).
- CLRB annual ROE is now at all-time high.
Performance
CLRB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-519.88%
+1591.18%+75.37%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly return on equity is -519.88%, with the most recent change of +1591.18% (+75.37%) on September 30, 2024.
- Over the past year, CLRB quarterly ROE has dropped by -1310.31% (-165.77%).
- CLRB quarterly ROE is now -105.88% below its all-time high of 8848.74%, reached on March 31, 2024.
Performance
CLRB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLRB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +172.4% | -165.8% |
| 3 y3 years | +1124.1% | -1014.7% |
| 5 y5 years | +382.6% | -358.8% |
CLRB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.4% | -105.9% | +95.2% |
| 5 y | 5-year | at high | +172.4% | -105.9% | +95.2% |
| alltime | all time | at high | +108.3% | -105.9% | +95.2% |
Cellectar Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -519.88%(-75.4%) |
| Jun 2024 | - | -2111.06%(-123.9%) |
| Mar 2024 | - | 8848.74%(+1019.5%) |
| Dec 2023 | 282.15%(-172.4%) | 790.43%(-107.3%) |
| Sep 2023 | - | -10.86 K%(+2019.3%) |
| Jun 2023 | - | -512.57%(+89.0%) |
| Mar 2023 | - | -271.25%(+45.7%) |
| Dec 2022 | -389.94%(+434.2%) | -186.17%(+58.9%) |
| Sep 2022 | - | -117.19%(+37.8%) |
| Jun 2022 | - | -85.06%(+27.1%) |
| Mar 2022 | - | -66.95%(+14.8%) |
| Dec 2021 | -73.00%(+165.0%) | -58.34%(+25.1%) |
| Sep 2021 | - | -46.64%(-3.5%) |
| Jun 2021 | - | -48.33%(-2.8%) |
| Mar 2021 | - | -49.71%(-20.8%) |
| Dec 2020 | -27.55%(-82.3%) | -62.73%(-46.7%) |
| Sep 2020 | - | -117.66%(-7.9%) |
| Jun 2020 | - | -127.71%(-5.9%) |
| Mar 2020 | - | -135.73%(+13.5%) |
| Dec 2019 | -155.56%(+55.8%) | -119.63%(+5.6%) |
| Sep 2019 | - | -113.32%(+16.2%) |
| Jun 2019 | - | -97.56%(-18.6%) |
| Mar 2019 | - | -119.79%(-4.3%) |
| Dec 2018 | -99.83%(-20.8%) | -125.19%(-7.7%) |
| Sep 2018 | - | -135.60%(-25.8%) |
| Jun 2018 | - | -182.86%(+18.5%) |
| Mar 2018 | - | -154.34%(+22.2%) |
| Dec 2017 | -126.11%(+176.3%) | -126.28%(+19.7%) |
| Sep 2017 | - | -105.53%(+11.2%) |
| Jun 2017 | - | -94.92%(+7.5%) |
| Mar 2017 | - | -88.29%(+20.2%) |
| Dec 2016 | -45.65%(-86.3%) | -73.44%(+51.2%) |
| Sep 2016 | - | -48.58%(-19.2%) |
| Jun 2016 | - | -60.14%(-53.8%) |
| Mar 2016 | - | -130.18%(-45.0%) |
| Dec 2015 | -333.07%(+177.0%) | -236.56%(-13.4%) |
| Sep 2015 | - | -273.18%(+140.6%) |
| Jun 2015 | - | -113.55%(-16.1%) |
| Mar 2015 | - | -135.37%(-30.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -120.23%(-81.0%) | -194.27%(-35.0%) |
| Sep 2014 | - | -298.88%(-79.3%) |
| Jun 2014 | - | -1440.64%(+280.2%) |
| Mar 2014 | - | -378.95%(+64.3%) |
| Dec 2013 | -634.43%(+632.6%) | -230.63%(+74.2%) |
| Sep 2013 | - | -132.42%(+8.2%) |
| Jun 2013 | - | -122.36%(+14.4%) |
| Mar 2013 | - | -107.00%(+13.8%) |
| Dec 2012 | -86.60%(+10.4%) | -94.04%(+0.4%) |
| Sep 2012 | - | -93.69%(-7.1%) |
| Jun 2012 | - | -100.83%(-13.3%) |
| Mar 2012 | - | -116.35%(-9.7%) |
| Dec 2011 | -78.42%(-97.7%) | -128.80%(-25.4%) |
| Sep 2011 | - | -172.62%(-183.8%) |
| Jun 2011 | - | 205.97%(+348.8%) |
| Mar 2011 | - | 45.89%(-311.1%) |
| Dec 2010 | -3408.30%(-4215.8%) | -21.74%(-141.0%) |
| Sep 2010 | - | 52.97%(-11.4%) |
| Jun 2010 | - | 59.80%(-12.3%) |
| Mar 2010 | - | 68.17%(-44.4%) |
| Dec 2009 | 82.81%(-1.9%) | 122.60%(+73.2%) |
| Sep 2009 | - | 70.80%(-6.5%) |
| Jun 2009 | - | 75.74%(-12.8%) |
| Mar 2009 | - | 86.86%(-12.3%) |
| Dec 2008 | 84.42%(-110.2%) | 99.02%(-37.3%) |
| Sep 2008 | - | 157.85%(-60.0%) |
| Jun 2008 | - | 394.58%(-125.4%) |
| Mar 2008 | - | -1555.77%(+404.3%) |
| Dec 2007 | -825.28%(+663.5%) | -308.50%(+99.7%) |
| Sep 2007 | - | -154.47%(+42.8%) |
| Jun 2007 | - | -108.16%(+52.2%) |
| Mar 2007 | - | -71.05%(+6.2%) |
| Dec 2006 | -108.09%(+67.1%) | -66.89%(+19.3%) |
| Sep 2006 | - | -56.08%(+11.0%) |
| Jun 2006 | - | -50.50%(-10.6%) |
| Mar 2006 | - | -56.50%(-50.2%) |
| Dec 2005 | -64.67% | -113.48%(-2.7%) |
| Sep 2005 | - | -116.62%(-56.2%) |
| Jun 2005 | - | -266.08%(-174.1%) |
| Mar 2005 | - | 359.32% |
FAQ
- What is Cellectar Biosciences annual return on equity?
- What is the all time high annual ROE for Cellectar Biosciences?
- What is Cellectar Biosciences annual ROE year-on-year change?
- What is Cellectar Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly ROE year-on-year change?
What is Cellectar Biosciences annual return on equity?
The current annual ROE of CLRB is 282.15%
What is the all time high annual ROE for Cellectar Biosciences?
Cellectar Biosciences all-time high annual return on equity is 282.15%
What is Cellectar Biosciences annual ROE year-on-year change?
Over the past year, CLRB annual return on equity has changed by +672.09% (+172.36%)
What is Cellectar Biosciences quarterly return on equity?
The current quarterly ROE of CLRB is -519.88%
What is the all time high quarterly ROE for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly return on equity is 8848.74%
What is Cellectar Biosciences quarterly ROE year-on-year change?
Over the past year, CLRB quarterly return on equity has changed by -1310.31% (-165.77%)